Quibim develops AI products for medical imaging, including QP-Prostate, QP-Brain, QP-Liver and QP-Insights.
Quibim, S.L., established in 2015 and headquartered in Valencia, Spain, develops artificial intelligence products for medical imaging, including QP-Prostate, QP-Brain, QP-Liver and QP-Insights, which aim to improve diagnostic accuracy and data management for hospitals and research institutions. Founder Ángel Alberich-Bayarri is also CEO. The company raised EUR 47.9 mn in Series A funding on January 16, 2025, with support from Adara Ventures and Amadeus Capital Partners. Its 2023 revenue was EUR 2,094,654.10.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in